CAS 1040250-19-8

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Virtual Booth

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

CHEMISTRY

Discover Molecule Insights

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 1040250-19-8, Scw5uz5maz, Unii-scw5uz5maz, Olmesartan medoxomil impurity iv, Amy3302, Dtxsid50856130

Molecular Formula

C₄₈H₅₀N₁₂O₅

Molecular Weight

875.0 g/mol

InChI Key

QTZDCAYLDWDQKW-UHFFFAOYSA-N

1 2D Structure

CAS 1040250-19-8

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

5-[2-[5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carbonyl]oxypropan-2-yl]-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid

2.1.2 InChI

InChI=1S/C48H50N12O5/c1-7-13-37-49-41(47(3,4)64)40(60(37)28-30-21-25-32(26-22-30)34-16-10-12-18-36(34)44-53-57-58-54-44)46(63)65-48(5,6)42-39(45(61)62)59(38(50-42)14-8-2)27-29-19-23-31(24-20-29)33-15-9-11-17-35(33)43-51-55-56-52-43/h9-12,15-26,64H,7-8,13-14,27-28H2,1-6H3,(H,61,62)(H,51,52,55,56)(H,53,54,57,58)

2.1.3 InChI Key

QTZDCAYLDWDQKW-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)C(C)(C)OC(=O)C5=C(N=C(N5CC6=CC=C(C=C6)C7=CC=CC=C7C8=NNN=N8)CCC)C(C)(C)O

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 1040250-19-8

2. Scw5uz5maz

3. Unii-scw5uz5maz

4. Olmesartan Medoxomil Impurity Iv

5. Amy3302

6. Dtxsid50856130

7. Bcp27850

8. Zinc150350216

9. Ft-0673276

10. J-502807

11. 1-((2'-(1h-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(2-((1-((2'-(1h-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(2-hydroxypro Pan-2-yl)-2-propyl-1h-imidazole-5-carbonyl)oxy)propan-2-yl)-2-propyl

12. 1-((2'-(2h-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(2-((1-((2'-(2h-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1h-imidazole-5-carbonyl)oxy)propan-2-yl)-2-propyl-1h-imidazole-5-carboxylic Acid

13. 1-(5-carboxy-2-propyl-1-((2'-(2h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1h-imidazol-4-yl)-1-methylethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(2h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1h-imidazole-5-carboxylate

14. 1h-imidazole-5-carboxylic Acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(2h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, 1-(5-carboxy-2-propyl-1-((2'-(2h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1h-imidazol-4-yl)-1-methylethyl Ester

15. 4-(2-(4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(2h-1,2,3,4-tetrazol-5-yl)-(1,1'-biphenyl)-4-yl)methyl)-1h-imidazole-5-carbonyloxy)propan-2-yl)-2-propyl-1-((2'-(2h-1,2,3,4-tetrazol-5-yl)-(1,1'-biphenyl)-4-yl)methyl)-1h-imidazole-5-carboxylic Acid

16. 4-(2-{[4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(2h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1h-imidazole-5-carbonyl]oxy}propan-2-yl)-2-propyl-1-{[2'-(2h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1h-imidazole-5-carboxylic Acid

2.3 Create Date

2013-06-10

3 Chemical and Physical Properties

Molecular Formula	C₄₈H₅₀N₁₂O₅
Molecular Weight	875.0 g/mol
XLogP3	7.3
Hydrogen Bond Donor Count	4
Hydrogen Bond Acceptor Count	13
Rotatable Bond Count	18
Exact Mass	874.40271274 g/mol
Monoisotopic Mass	874.40271274 g/mol
Topological Polar Surface Area	228 Å²
Heavy Atom Count	65
Formal Charge	0
Complexity	1550
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

CAS 1040250-19-8 manufacturers and suppliers on PharmaCompass

CHEMISTRY

Discover Molecule Insights

What are you looking for?